Health Atlas
Menu
Evidence-led reference

Mental wellbeing

Agoraphobia: feared situations, avoidance and finding care

10 sources · Latest source check 2026-10-20 UTC
On this page

Agoraphobia concerns situations where escaping or getting help feels difficult if symptoms leave someone unable to cope. Avoidance can restrict travel, shopping and social life, even when someone can sometimes go out.[1]

Different places can share the same feared problem

Assessment considers excessive fear lasting at least six months in two or more categories: public transport, open spaces, enclosed places, queues or crowds, and being alone outside home. Distress, functioning and actual circumstances matter. Counting places is not a self-diagnosis.[2]

Physical conditions can affect fear and mobility. New physical symptoms need assessment; clinicians consider whether avoidance exceeds limitations explained by an underlying condition.[2]

Explain what you fear will happen, not just where you avoid

Describe your symptoms, feared outcomes, avoided activities and other health conditions to a clinician. Explain when difficulties began and how they restrict life. Ask about an initial phone or video appointment if travel prevents access.[3]

Exposure is planned practice in real situations

Cognitive behavioural therapy (CBT) can help someone test feared predictions and return gradually to avoided activities. Exposure means approaching an agreed situation repeatedly in manageable steps, with a therapist's plan. For example, goals might progress from a short local outing to a bus journey. The plan should consider health, actual safety and the person's circumstances.[3]

A treatment plan includes preferences and a way to review progress

The German guideline report supports CBT, medicine or a combination according to needs and preferences. If a treatment is ineffective, clinicians can reassess and consider another approach or a combination. A fixed number of sessions is not established for every person. Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressant medicines also used in anxiety care.[4]

Evidence & uncertainty

Much treatment research includes panic disorder with or without agoraphobia. It cannot automatically answer every question about agoraphobia occurring without panic disorder.[6]

Selected-source overview · Independent review pending

Published questions

Can fear of falling or losing bladder control be part of agoraphobia?

Selected-source overview · Independent review pending. Read the evidence context.

Yes. Some people fear symptoms such as falling or losing bladder control, rather than panic itself. That fear alone does not establish a diagnosis: assessment also considers persistence, impact and circumstances. Agoraphobia is assessed separately rather than requiring a preceding panic-disorder diagnosis.[9]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can I have agoraphobia if I still sometimes go out?

Selected-source overview · Independent review pending. Read the evidence context.

Yes. Severity varies. Someone may travel a limited distance, go only with another person or endure an outing with substantial fear. Being completely housebound is not required, and occasional successful outings do not describe the whole pattern.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Why might I have few panic-like symptoms while staying home?

Selected-source overview · Independent review pending. Read the evidence context.

Avoiding feared situations can mean rarely encountering the triggers for physical symptoms. The resulting restrictions can still be important. Tell the clinician both what happens during outings and what you have stopped doing, rather than describing only symptoms on a quiet day at home.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does needing someone with me prove I have agoraphobia?

Selected-source overview · Independent review pending. Read the evidence context.

No. Needing a companion is one feature within a broader assessment. Clinicians consider persistence, distress, functioning and other explanations. A companion can help access care; their presence is not a diagnosis.[2]

Evidence behind this answer
  • Agoraphobia

    clinical reference · 2026
    Article body read; full review April 2026, updated July 2026; old route redirects · Situation categories, clinical criteria and differential assessment

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

How is agoraphobia distinguished from other reasons for staying home?

Selected-source overview · Independent review pending. Read the evidence context.

Assessment considers what drives the fear, actual danger, physical limitations and other conditions. Fear primarily about social judgment or a perceived appearance flaw may suggest a different problem. Staying home alone cannot identify one cause.[2]

Evidence behind this answer
  • Agoraphobia

    clinical reference · 2026
    Article body read; full review April 2026, updated July 2026; old route redirects · Situation categories, clinical criteria and differential assessment

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

How can I start treatment if I cannot get to an office?

Selected-source overview · Independent review pending. Read the evidence context.

Ask about a phone or video appointment, an initial home visit or meeting in a manageable location. Services differ. A trusted person may help with the first appointment. Explain the travel barrier when contacting the service.[3]

Evidence behind this answer
  • Agoraphobia: diagnosis and treatment

    clinical explanation · 2023
    Full public diagnosis/treatment body read; dated 7 January 2023 · Interview, practical access alternatives and collaborative gradual exposure

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does exposure mean forcing myself into the busiest place?

Selected-source overview · Independent review pending. Read the evidence context.

No. It means planned practice that gradually approaches feared situations, agreed with a therapist. Goals should be predictable and manageable enough to practise repeatedly. Discuss physical health, safety and needed support; a sudden overwhelming challenge is not the definition of exposure therapy.[3]

Evidence behind this answer
  • Agoraphobia: diagnosis and treatment

    clinical explanation · 2023
    Full public diagnosis/treatment body read; dated 7 January 2023 · Interview, practical access alternatives and collaborative gradual exposure

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can a therapist help during practice outside the office?

Selected-source overview · Independent review pending. Read the evidence context.

In a trial of people with panic disorder and agoraphobia, therapist-accompanied exposure added benefits beyond therapist-planned exercises alone. This supports asking how real-world practice will be supported. It does not establish that everyone needs accompaniment for every outing or the same number of visits.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can an agoraphobia app replace therapy?

Selected-source overview · Independent review pending. Read the evidence context.

The app trial discussed here did not test that question. It compared two self-guided apps, found no clear difference and lacked a group receiving no app. Improvement in both groups cannot establish treatment efficacy. Ask about assessment, guidance and a plan for worsening symptoms before relying on a digital tool.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is virtual-reality therapy proven for everyone with agoraphobia?

Selected-source overview · Independent review pending. Read the evidence context.

No. The gameChange trial concerned anxious avoidance in people with psychosis and compared added VR treatment with usual care alone. It found short-term benefit in that context. This does not establish equal benefit for other populations, superiority to standard CBT or suitability of an unrelated commercial product.[8]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can medicine help if I also have panic disorder?

Selected-source overview · Independent review pending. Read the evidence context.

A review found benefit from several medicine classes for panic-disorder remission, including SSRIs, while adverse effects remained relevant. Most studies had methodological concerns. Discuss the target symptoms, likely benefits, risks and follow-up with a prescriber; results for panic disorder should not be treated as precise predictions for standalone agoraphobia.[10]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

How many therapy sessions should recovery take?

Selected-source overview · Independent review pending. Read the evidence context.

There is no evidence-based single number for everyone. The guideline report found insufficient reliable data to specify a necessary duration. Agree practical goals and review progress, support needs and alternatives with the clinician. A study's schedule is not an individual deadline.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Agoraphobia can be studied separately from panic disorder

A cross-national survey report examined 136,357 adults from 27 countries and compared diagnostic definitions. The newer definition identified a partly different group from the older one despite similar overall prevalence. The study supports assessing agoraphobia in its own right rather than assuming it follows panic disorder. However, the newer diagnostic algorithm was applied retrospectively to existing interview questions and did not match every criterion perfectly.[9]

Therapist involvement during outings can matter

A 2011 trial involved 369 people with panic disorder and agoraphobia. Two CBT programmes differed in whether therapists accompanied exposure outside the therapy room or planned and discussed exercises without accompanying patients. Both outperformed a waiting list; accompanied exposure produced additional improvement in avoidance and some other outcomes through six-month follow-up. Both active groups received structured therapy. The trial does not mean that an unsupported solo outing is equivalent to either programme.[5]

An app comparison did not establish benefit over no app

A 12-week trial assigned 170 people who identified themselves as having agoraphobia to an agoraphobia-focused app or a general anxiety app. Both groups improved, without a significant difference between them. There was no no-treatment or waiting-list group to separate app effects from change over time, and no later follow-up. These findings do not show that a particular app replaces assessment or supported therapy.[7]

Virtual-reality evidence comes from a specific population

The 2022 gameChange trial enrolled 346 people with psychosis and difficulty going outside because of anxiety. Adding a virtual-reality therapy programme to usual care reduced avoidance and distress at six weeks compared with usual care alone; average standardized effects were small. This was a programme for people receiving psychosis care, not a trial of every person with agoraphobia or a comparison with standard CBT. Applicability and access need individual discussion.[8]

Medicine findings need their diagnostic context

A 2022 review of 87 trials involving 12,800 adults with panic disorder, with or without agoraphobia, found that several medicine classes increased remission compared with placebo. SSRIs had a relatively favourable balance of remission and adverse events, but adverse effects still occurred. Almost all studies had some concerns or high risk of bias. These results concern panic-disorder populations; they are not direct estimates for agoraphobia without panic disorder.[10]

Treatment comparisons remain less certain than a simple ranking suggests

A 2016 Cochrane review included 60 psychotherapy studies in adults with panic disorder, with or without agoraphobia. Talking therapies generally performed better than no treatment, but low- or very-low-quality evidence did not establish a clear winner among therapies. That older comparison does not overturn guideline recommendations based on a broader assessment of evidence, nor does it isolate agoraphobia without panic disorder.[6]

The German guideline authors found insufficient reliable evidence to specify one necessary psychotherapy duration. Ask which goals will show progress, how practice will be supported and when to review the plan. Limited progress warrants reassessment rather than a conclusion that the person has failed.[4]

References

  1. Agoraphobia: overview, symptoms and treatment

    Agency explanation

    NHS · Content/publication date: 2022
    Accessed: 2026-10-20 UTC · Full public linked pages read; page review date 31 October 2022
    Cited sections: Escape/help fears, severity and effects of avoidance

    Linked pages grouped; existing anxiety-guide use included.

  2. Agoraphobia

    Clinical reference

    Barnhill; Merck Manual Professional Edition · Content/publication date: 2026
    Accessed: 2026-10-20 UTC · Article body read; full review April 2026, updated July 2026; old route redirects
    Cited sections: Situation categories, clinical criteria and differential assessment

    Clinical criteria require contextual assessment.

  3. Agoraphobia: diagnosis and treatment

    Clinical explanation

    Mayo Clinic · Content/publication date: 2023
    Accessed: 2026-10-20 UTC · Full public diagnosis/treatment body read; dated 7 January 2023
    Cited sections: Interview, practical access alternatives and collaborative gradual exposure

    Options and availability differ between services.

  4. The German Guidelines for the treatment of anxiety disorders: first revision

    Clinical guideline

    Bandelow and colleagues · Content/publication date: 2021
    Accessed: 2026-10-20 UTC · Original guideline report and relevant recommendation sections read
    Cited sections: Psychotherapy, medication, treatment preference and limited evidence for duration

    Guideline report; panic/agoraphobia often studied together.

  5. Psychological Treatment for Panic Disorder with Agoraphobia: A Randomized Controlled Trial to Examine the Role of Therapist-Guided Exposure In Situ in CBT

    Randomized trial

    Gloster and colleagues · Content/publication date: 2011
    Accessed: 2026-10-20 UTC · Complete original abstract and metadata read in author-institution repository; PubMed body unavailable
    Cited sections: 369 patients; therapist-accompanied versus therapist-planned exposure and waiting list

    Panic disorder with agoraphobia; six-month follow-up.

  6. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis

    Systematic review

    Pompoli and colleagues; Cochrane · Content/publication date: 2016
    Accessed: 2026-10-20 UTC · Public review summary and abstract read; searches through March 2015
    Cited sections: 60 studies; comparative uncertainty and panic-disorder population

    Older synthesis; does not isolate agoraphobia without panic.

  7. Two Novel Cognitive Behavioral Therapy–Based Mobile Apps for Agoraphobia: Randomized Controlled Trial

    Randomized trial

    Christoforou, Sáez Fonseca and Tsakanikos · Content/publication date: 2017
    Accessed: 2026-10-20 UTC · Original full text, abstract and limitations read
    Cited sections: 170 self-identifying participants; two active apps, no time-control group or later follow-up

    Improvement within groups does not establish app efficacy.

  8. Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre randomized controlled trial

    Randomized trial

    Freeman and colleagues · Content/publication date: 2022
    Accessed: 2026-10-20 UTC · Complete original abstract and metadata read in author-institution repository
    Cited sections: 346 patients with psychosis and anxious avoidance; six-week primary outcomes

    Psychosis population; usual-care comparator, not standard-CBT comparison.

  9. A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys

    Cross sectional study

    Roest and colleagues · Content/publication date: 2019
    Accessed: 2026-10-20 UTC · Original full-text abstract, diagnostic introduction and limitations read
    Cited sections: Independent diagnosis, symptom criteria and cross-national survey limitations

    Retrospective diagnostic algorithm; not an individual test.

  10. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials

    Systematic review

    Chawla and colleagues · Content/publication date: 2022
    Accessed: 2026-10-20 UTC · Original full-text abstract and limitations read
    Cited sections: 87 studies, 12,800 participants; remission, adverse events and study bias

    Panic-disorder trials; not standalone-agoraphobia efficacy estimates.

Scope & review

Population
People with escape/help-related fear and avoidance; research populations distinguished from standalone agoraphobia
Exposure or intervention
Assessment, supported CBT and exposure, access adaptations, medicine and digital approaches
Comparison
Other reasons for avoidance; therapist-guided versus planned exposure, active apps, usual care and placebo
Outcomes
Avoidance, distress, functioning, panic remission and harms
Timeframe
Clinical assessment and selected short-term studies with limited follow-up
Jurisdiction
Educational overview; local access and prescribing arrangements vary

Clinical criteria and public guidance plus selected original trials, observational diagnostic research and syntheses read. Population and access limits retained; not an exhaustive search or qualified psychiatric review.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-20 UTC: Initial educational authorship; foundations precede evidence; publication identities checked; qualified psychiatric review pending.

What this article still leaves open

  • Which supported approaches best treat agoraphobia without panic disorder, and sustain gains in everyday functioning?
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.